1-4 of 4
Allison Imahiyerobo
Close
Sort by
Journal Articles

Safety and Efficacy Of Eltrombopag At Escalated Doses Up To 150mg In Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive To 75 Mg

Catherine E. McGuinn, MD, Allison Imahiyerobo, ANP- BC, Micha Thompson, B.A., Naznin Haq, B.A., Claudia Tchatchouang, M.A., James B Bussel, MD
Journal: Blood
Blood (2013) 122 (21): 3559.
https://doi.org/10.1182/blood.V122.21.3559.3559
Published: 2013
Journal Articles

Bone Marrow Fibrosis In Immune Thrombocytopenia (ITP) Patients Treated With Thrombopoietin Receptor Agonists (TRA) – a Single Center Long-Term Follow-Up

Waleed Ghanima, MD, PhD, Julia Turbiner Geyer, MD, Christina Soo Lee, BA, Attilio Orazi, MD, Leonardo Boiocchi, MD, Allison Imahiyerobo, James B. Bussel, MD
Journal: Blood
Blood (2013) 122 (21): 3527.
https://doi.org/10.1182/blood.V122.21.3527.3527
Published: 2013
Journal Articles

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Christina S Lee, B.A., Allison Imahiyerobo, ANP-BC, Micha Thompson, B.A., Marina Izak Karaev, M.D., Waleed Ghanima, MD, PhD, James B Bussel, MD
Journal: Blood
Blood (2013) 122 (21): 2310.
https://doi.org/10.1182/blood.V122.21.2310.2310
Published: 2013
Journal Articles

Cyclosporine-Romiplostim-IVIG Combination Therapy In Patients With Severe Immune Thrombocytopenia (ITP)

Sif Gudbrandsdottir, MD, Emily Leven, Allison Imahiyerobo, ANP-BC, Soo Lee, James B. Bussel, MD
Journal: Blood
Blood (2013) 122 (21): 1085.
https://doi.org/10.1182/blood.V122.21.1085.1085
Published: 2013